Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE829A01014
Key metrics
- Market Cap
- ₹54 Cr
- P/E Ratio
- 109.77
- EPS
- 0.3
- Book Value
- 13.25
- P/B Ratio
- 2.48
- ROE
- 12.92%
- ROCE
- 1.54%
- Debt / Equity
- 0.14
- Net Margin
- 9.81%
- Revenue Growth
- -14.99%
- Profit Growth
- 399.46%
- Dividend Yield
- —
- 52W High
- ₹46.34
- 52W Low
- ₹25.60
- Market Cap Band
- micro cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Biofil Chemicals and Pharmaceuticals Limited
Biofil Chemicals and Pharmaceuticals Limited engages in the manufacturing and trading of pharmaceutical products in India. It operates through Pharma and Chemical segments. The company offers basic drugs and chemicals, including sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrus fumerate, micro crystalline cellulose, and dicyclomine hydrochloride. It also provides ferrous sulphate in crystal, exsiccated, and granular form; microcrystalline cellulose powder; cellulose powder; calcium carbonate; and sodium chloride. In addition, the company offers job work facility for manufacturing of pharmaceuticals drug. Biofil Chemicals and Pharmaceuticals Limited was founded in 1985 and is based in Indore, India
- Headquarters
- Indore, India
- Promoter Holding
- 58.08%
The full Biofil Chemicals and Pharmaceuticals Limited analysis
Create a free account to open the complete BIOFILCHEM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.